Triple therapy, including two antibiotics, amoxicillin and clarithromycin, and a proton pump
inhibitor given for a week has been recommended as the treatment of choice at several …

Helicobacter pylori causes a serious bacterial infectious disease, and the expectations of
therapy should reflect this fact. Increasing antibiotic resistance, especially to clarithromycin …

Background Information regarding the effects of drug resistance on therapies for
Helicobacter pylori is limited. Aims To determine the effect of drug resistance on the efficacy …

Bacterial culture has played an irreplaceable role in the discovery and characterisation of
Helicobacter pylori. The main topic of the present article is to critically review the role of …

Background The current prevalence of primary antibiotic resistance of H. pylori is not known
in Korea. This study was done to evaluate the prevalence of primary antibiotic resistance of …

BACKGROUND: The use of Helicobacter pylori eradication therapy is advocated in an
increasing variety of situations. It is therefore important to optimise current strategies to …

抄録 A triple therapy based on a proton pump inhibitor (PPI), amoxicillin (AMPC), and
clarithromycin (CAM) is recommended as a first-line therapy for Helicobacter pylori (H …

Objective The Taiwan Government issued a policy to restrict antimicrobial usage since 2001.
We aimed to assess the changes in the antibiotic consumption and the primary resistance of …

Helicobacter pylori infection is associated with chronic gastritis, peptic ulcers, and gastric
cancer. The flavonoid compounds baicalin and baicalein found in many medicinal plants …

Results All of these patients were treated with the same regimen, proton pump inhibitor-
amoxicillin-clarithromycin triple therapy. There was a statistical difference in resistance to …